Daruka Mahadevan, MD, PhD, division chief, hematology-oncology, director of the Institute of Drug Development and associate director for clinical research at Mays Cancer Center at UT Health San Antonio and his team have identified a series of small molecule compounds that target an enzyme, MAP4K3, important to amino acid signaling in autophagy, impacting neurologic diseases and cancer.

This bread is sure to be a holiday favorite. It brings together two of the season's most beloved flavors: cranberry and pumpkin, to create a tasty, disease-fighting treat.

This 5-minute wrap is both easy and full of cancer-fighting fruit and vegetables along with essential vitamins. It's perfect for a quick lunch on the go!

We are excited to announce that Lydia Herrera, PharmD, MBA, has been appointed the director of oncology pharmacy operations position at the Mays Cancer Center.